Clinical trial Recruiting at 1 site Interventional Ages 10 to 18

Using open-label placebos to manage pain after scoliosis surgery in adolescents

Official title: Effectiveness of Conditioning + Open-label Placebo for the Management of Pain in Children Who Undergo Surgical Treatment of Idiopathic Scoliosis

Run by University of California, San Francisco · NCT06365892 · Data updated 2026-11-12

This study tests if giving teenagers open-label placebos along with regular pain treatment after scoliosis surgery can help them use less pain medication and recover faster.

More Adolescent Idiopathic Scoliosis (AIS) trials

Quick facts

Study typeInterventional
Ages10 Years to 18 Years
SexAll
Enrollment64 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Locations1 site (San Francisco, California)
StatusRecruiting
StartedJuly 1, 2024
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedMarch 13, 2026
Trial IDNCT06365892 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adolescents aged 10 to 18 diagnosed with idiopathic scoliosis who are undergoing their primary surgical procedure.

Probably not a fit

Patients with non-idiopathic scoliosis, those undergoing revision procedures, or individuals currently taking opioids may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of conditioning with open-label placebos on postoperative pain management for adolescents undergoing surgery for idiopathic scoliosis. A total of 64 participants aged 10 to 18 will be randomly assigned to receive either open-label placebos in addition to standard treatment or standard treatment alone. The study will assess opioid consumption and recovery metrics over a 6-week period, utilizing surveys and clinical data collection to evaluate outcomes. The trial aims to determine if the use of open-label placebos can reduce opioid use and improve recovery times compared to standard treatment.

Why it matters

Potential benefit: If successful, this approach could lead to reduced opioid consumption and improved recovery outcomes for adolescents undergoing scoliosis surgery.

How similar studies have gone: While the use of open-label placebos is a novel approach in this context, similar studies have shown promise in other areas of pain management.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

To be eligible for enrollment, patients must meet all of the following inclusion criteria:

1. Diagnosis of idiopathic spine deformity.
2. Age \>10 and \<18 years.
3. Primary procedure.
4. Guardian provides signed and dated informed consent and understand the nature of the study sufficiently to allow completion of all study assessments.
5. Patient provides assent.
6. Fusion and fusionless instrumented spine surgery.

Exclusion Criteria:

If any of the following exclusion criteria are met, the patient is not eligible for the study:

1. Non-idiopathic scoliosis, such as neuromuscular or syndrome.
2. Revision procedure.
3. Self-reported pregnancy or planned pregnancy within the next two months.
4. Have a history of drug, excluding nicotine or caffeine, or alcohol abuse within 2 years of entry into the study
5. Already taking opioids.
6. Abnormal physical examination.
7. Inability to speak or read English
8. Patient declines participation.

Where it's running

  • University of California, San Francisco
    San Francisco, California, United States
    Recruiting

Study contacts

  • Principal investigator: Mohammad Diab, MD — University of California, San Francisco
  • Study coordinator: Mohammad Diab, MD
  • Email: mohammad.diab@ucsf.edu
  • Phone: 415-514-1519

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.